Premium
The association of time of day and serum testosterone concentration in a large screening population
Author(s) -
Crawford E. David,
Barqawi Al Baha,
O’Donnell Colin,
Morgentaler Abraham
Publication year - 2007
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2007.07022.x
Subject(s) - testosterone (patch) , medicine , morning , prostate cancer , prostate cancer screening , population , semen , prostate , gynecology , prostate specific antigen , cancer , physiology , andrology , environmental health
Authors from the USA reviewed semen samples for their National Prostate Cancer Awareness screening programme. They evaluated semen testosterone levels at various times during the day, depending on when the person attended for screening. In this study, they found that testosterone levels in older men remain stable throughout the morning and early afternoon, and declined only moderately after that. Further case control studies have been suggested to confirm this finding. In a study from the UK, changes to PSA screening programmes, such as lowering the threshold or incorporating reflex PSA tests, have been looked at, particularly their impact on programme performance characteristics. The authors found that such changes will increase the number of biopsies and the number of cancers detected, but the authors question whether this will improve treatment outcomes. OBJECTIVE To assess testosterone patterns during clinical hours in a large population of men participating in a national screening programme for prostate cancer, as the effect of time of day on serum testosterone concentration is unclear and largely reported in small studies. SUBJECTS AND METHODS Testosterone levels were measured in 3006 men attending the national Prostate Cancer Awareness Week screening programme. Blood samples were obtained between 06.00 and 18.00 hours, whenever men presented for screening. All men completed questionnaires on age, comorbidities, height and weight. Testosterone levels were compared based on four periods, i.e. T1, 06.00–10.00 (632 men), T2, 10.00–12.00 (812), T3, 12.00–14.00 (388), and T4, 14.00–18.00 hours (1174). RESULTS The mean ( sd , range) age of the men was 60.3 (9.9, 40–94) years and the mean ( sd ) testosterone level was 415.2 (190.9) ng/dL. There was no change in mean ( sd ) testosterone levels over T1, T2 and T3, at 444.9 (206.2), 433.5 (195.8) and 434.4 (181.2) ng/dL, respectively, but levels at T4, at 380.4 (176.4) ng/dL, were lower by ≈ 13% ( P < 0.05). Advancing age, diabetes and obesity were associated with lower testosterone levels. The percentage of men with biochemical hypogonadism (<300 ng/dL) did not change across all four periods. CONCLUSIONS Testosterone levels in older men are stable throughout the morning and early afternoon, declining only modestly thereafter. Further case‐controlled studies are needed to confirm these findings.